Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Percutaneous transrenal ureteroneocystostomy.

¹Department of Urology, Bajcsy Zs. Hosp., Budapest, Hungary.

Journal of Endourology

|August 14, 1999

Summary

Advanced prostate cancer can block ureters. A novel antegrade percutaneous ureteroneocystostomy technique successfully treated a patient when standard ureteral stenting failed, offering a new treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Results in the treatment of renal tumours.

Acta chirurgica Hungarica·1994

Same author

[Immunotherapy of superficial bladder tumors in a hospital department].

Orvosi hetilap·1993

Same author

[Experience with percutaneous kidney stone removal based on 150 cases].

Orvosi hetilap·1987

Same author

[Successful surgical correction of bilateral ureteral compression after aortofemoral bypass surgery].

Orvosi hetilap·1987

Same author

Procedures increasing the effectivity of percutaneous nephrolithotomy.

Acta chirurgica Hungarica·1987

Same author

Observations with Magurlit in the treatment of patients with uric acid stone.

Therapia Hungarica (English edition)·1984

Area of Science:

Urology
Oncology

Background:

Advanced prostate carcinoma obstructs the ureteral orifice in 10% of patients.
Standard ureteral stent placement may fail in complex cases.

Observation:

A patient with advanced prostate carcinoma experienced failed ureteral stent placement.
Antegrade percutaneous ureteroneocystostomy using the Lawson retrograde nephrostomy set was performed.

Findings:

The antegrade percutaneous ureteroneocystostomy with a double-J stent remained functional for 2 years post-procedure.
No decrease in anastomosis caliber was observed after stent removal at 8 months.

Implications:

This technique offers a viable alternative for managing ureteral obstruction in advanced prostate cancer.
Percutaneous antegrade ureteroneocystostomy provides a new therapeutic option for challenging cases.

Related Experiment Videos